CA2414409A1 - Enhancing therapeutic effectiveness of nitric oxide inhalation - Google Patents

Enhancing therapeutic effectiveness of nitric oxide inhalation Download PDF

Info

Publication number
CA2414409A1
CA2414409A1 CA002414409A CA2414409A CA2414409A1 CA 2414409 A1 CA2414409 A1 CA 2414409A1 CA 002414409 A CA002414409 A CA 002414409A CA 2414409 A CA2414409 A CA 2414409A CA 2414409 A1 CA2414409 A1 CA 2414409A1
Authority
CA
Canada
Prior art keywords
inhalation
endotoxin
mice
pulmonary
wild
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002414409A
Other languages
English (en)
French (fr)
Inventor
Kenneth D. Bloch
Fumito Ichinose
Warren M. Zapol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2414409A1 publication Critical patent/CA2414409A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA002414409A 2000-06-28 2001-06-22 Enhancing therapeutic effectiveness of nitric oxide inhalation Abandoned CA2414409A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/605,900 US6601580B1 (en) 2000-06-28 2000-06-28 Enhancing therapeutic effectiveness of nitric oxide inhalation
US09/605,900 2000-06-28
PCT/US2001/041102 WO2002000175A2 (en) 2000-06-28 2001-06-22 Enhancing therapeutic effectiveness of nitric oxide inhalation

Publications (1)

Publication Number Publication Date
CA2414409A1 true CA2414409A1 (en) 2002-01-03

Family

ID=24425654

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002414409A Abandoned CA2414409A1 (en) 2000-06-28 2001-06-22 Enhancing therapeutic effectiveness of nitric oxide inhalation

Country Status (10)

Country Link
US (2) US6601580B1 (https=)
EP (1) EP1301076A4 (https=)
JP (1) JP2004509850A (https=)
KR (1) KR100849103B1 (https=)
CN (1) CN100488497C (https=)
AU (2) AU2001273622B2 (https=)
CA (1) CA2414409A1 (https=)
IL (1) IL153702A0 (https=)
MX (1) MXPA03000182A (https=)
WO (1) WO2002000175A2 (https=)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656452B1 (en) 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
US20070086954A1 (en) * 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US7335181B2 (en) * 2000-12-26 2008-02-26 Pulmonox Technologies Corporation Nitric oxide decontamination of the upper respiratory tract
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
GB0125357D0 (en) * 2001-10-22 2001-12-12 Univ Brighton Improvements relating to catalytic antioxidants
KR100949318B1 (ko) * 2001-11-29 2010-03-23 사운드 파마슈티칼스 인코퍼레이티드 화학요법의 바람직하지 않은 작용을 개선하기 위한 방법과조성물
ES2497716T3 (es) * 2002-01-04 2014-09-23 Sound Pharmaceuticals Incorporated Composiciones para utilizar en métodos destinados a tratar la pérdida auditiva
WO2004000368A1 (en) * 2002-06-21 2003-12-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US9138707B2 (en) 2002-12-10 2015-09-22 Sy Kimball Portable, nitric oxide generator
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
ES2294543T3 (es) * 2003-07-09 2008-04-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Heal Uso de sales de nitrilo para el tratamiento de afecciones cardiovasculares.
US20050255178A1 (en) * 2004-02-04 2005-11-17 Bloch Kenneth D Enhancing the effectiveness of an inhaled therapeutic gas
AU2005244078A1 (en) 2004-05-11 2005-11-24 Pulmonox Technologies Corporation Intermittent dosing of nitric oxide gas
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
CA2600134A1 (en) * 2005-03-08 2006-09-14 Sound Pharmaceuticals Incorporated Methods and compositions for treating cancer
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
WO2007057763A2 (en) * 2005-11-18 2007-05-24 Pulmonox Technologies Corporation Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
US8790715B2 (en) 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
WO2007136789A2 (en) * 2006-05-19 2007-11-29 Medimmune, Inc. Methods of preventing, treating or ameliorating enhanced respiratory disease via innate immune mechanisms
FR2902002B1 (fr) * 2006-06-12 2010-08-27 Lvmh Rech Composition cosmetique anti-radicaux libres
US8079998B2 (en) * 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
WO2008063868A2 (en) * 2006-11-07 2008-05-29 The General Hospital Corporation Attenuation of vasoactive oxygen carrier-induced vasoconstriction
US20080193566A1 (en) * 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
CA2743334A1 (en) * 2007-11-12 2009-05-22 Samsara Medicin Ab Methods relating to breathing disorders
WO2009086470A2 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
US8720436B2 (en) * 2008-01-31 2014-05-13 Genosys, Inc. Nitric oxide gel apparatus and method
US8434475B2 (en) 2008-01-31 2013-05-07 Genosys, Inc. Nitric oxide reactor and distributor apparatus and method
US9649467B2 (en) 2008-01-31 2017-05-16 Syk Technologies, Llc Nitric oxide reactor and distributor apparatus and method
US8501090B2 (en) * 2008-03-24 2013-08-06 Christian S. Minton Anti-microbial gas apparatus and method
CA2671029A1 (en) 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
JP5581500B2 (ja) * 2010-03-10 2014-09-03 学校法人北里研究所 虚血再灌流障害軽減用治療剤および治療装置
US8685467B2 (en) 2010-08-03 2014-04-01 J. W. Randolph Miller Nitric oxide generation, dilution, and topical application apparatus and method
EP2691087A2 (en) 2011-03-31 2014-02-05 László Gábor Szabó Pharmaceutical composition containing no, process for the preparation and use thereof
CN104159591A (zh) 2011-11-07 2014-11-19 通用医疗公司 红细胞的处理
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
EP2908137A1 (en) * 2014-02-14 2015-08-19 Institut Pasteur Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
JP2014141536A (ja) * 2014-05-16 2014-08-07 Kitasato Institute 虚血再灌流障害軽減用治療剤および治療装置
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CA3009986A1 (en) * 2015-12-28 2017-07-06 Vero Biotech LLC Method and apparatus for administering nitric oxide with supplemental drugs
WO2017132275A1 (en) 2016-01-27 2017-08-03 Syk Technologies, Llc Nitric oxide topical application apparatus and methods
AU2017362500B2 (en) 2016-11-17 2024-09-26 Renovion, Inc. Treatment of Respiratory Tract Diseases and Infections with Ascorbic Acid Compositions
BR112020009910A2 (pt) 2017-11-17 2020-11-03 Renovion, Inc. composições de ácido ascórbico estáveis e métodos de usar as mesmas
CN109169638A (zh) * 2018-11-12 2019-01-11 苏州瑞徕生物科技有限公司 一种细胞保存液及其用途
US12459820B2 (en) 2020-06-11 2025-11-04 J. W. Randolph Miller Stabilized and NO2-inhibited nitric oxide generating gels for inhaled nitric oxide therapy
KR20240131358A (ko) 2022-01-04 2024-08-30 레노비온, 아이엔씨. 글루타치온 염을 포함하는 수용액

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
US5570683A (en) 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
WO1992010228A1 (en) 1990-12-05 1992-06-25 The General Hospital Corporation Devices for treating pulmonary vasoconstriction and asthma
AU6528494A (en) * 1993-04-06 1994-10-24 Brigham And Women's Hospital Nitric oxide combination therapy
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US5728705A (en) 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
WO1996039409A1 (en) * 1995-06-05 1996-12-12 Nitromed, Inc. Nitrosylated and nitrated superoxide oxidants and reductants
ATE331505T1 (de) 1996-04-05 2006-07-15 Gen Hospital Corp Behandlung einer hämoglobinstörung
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
SE9903985D0 (sv) * 1999-11-03 1999-11-03 Aga Ab Use of nitric oxide
CA2393724A1 (en) * 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use

Also Published As

Publication number Publication date
WO2002000175A3 (en) 2002-08-15
MXPA03000182A (es) 2004-02-26
EP1301076A2 (en) 2003-04-16
KR20030029530A (ko) 2003-04-14
JP2004509850A (ja) 2004-04-02
US6935334B2 (en) 2005-08-30
CN1635923A (zh) 2005-07-06
CN100488497C (zh) 2009-05-20
WO2002000175A2 (en) 2002-01-03
AU7362201A (en) 2002-01-08
EP1301076A4 (en) 2004-09-22
IL153702A0 (en) 2003-07-06
US6601580B1 (en) 2003-08-05
KR100849103B1 (ko) 2008-07-30
AU2001273622B2 (en) 2007-05-10
US20030202969A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
US6601580B1 (en) Enhancing therapeutic effectiveness of nitric oxide inhalation
AU2001273622A1 (en) Enhancing therapeutic effectiveness of nitric oxide inhalation
Roberts Jr et al. Inhaled nitric oxide in congenital heart disease.
Cepinskas et al. Inflammatory response in microvascular endothelium in sepsis: role of oxidants
JP5004391B2 (ja) Ｎｏ基化合物で心肺疾病を処置する方法
Mizutani et al. Clinical applications of nitric oxide
Fullerton et al. Inhaled nitric oxide: therapeutic applications in cardiothoracic surgery
Lange et al. Role of nitric oxide in shock: the large animal perspective
US20040228930A1 (en) Treatment for hemorrhagic shock
CN100443119C (zh) 一氧化氮的吸入
Sheridan et al. Low-dose inhaled nitric oxide in acutely burned children with profound respiratory failure
Swenson et al. Effects of carbonic anhydrase inhibition on ventilation-perfusion matching in the dog lung.
Enkhbaatar et al. Effect of inhaled nitric oxide on pulmonary vascular hyperpermeability in sheep following smoke inhalation
Lindberg et al. Nitric oxide gives maximal response after coronary artery bypass surgery
Oz et al. Collective review: perioperative uses of inhaled nitric oxide in adults
Greene et al. The Efficacy of Inhaled Nitric Oxide in the Treatment of Acute Respiratory Distress Syndrome: An Evidence-Based Medicine Approach
Abman et al. Inhaled nitric oxide therapy for pulmonary disease in pediatrics
ZA200300702B (en) Enhancing thereapeutic effectiveness of nitric oxide inhalation.
AU2007201877A1 (en) Enhancing therapeutic effectiveness of nitric oxide inhalation
Zapol et al. Inhaled nitric oxide in adult respiratory distress syndrome and other lung diseases
Lange et al. Effects of early neuronal and delayed inducible nitric oxide synthase blockade on cardiovascular, renal, and hepatic function in ovine sepsis
Hurford et al. Nitric oxide inhalation in the intensive care unit
Rossaint et al. Recent advances in the treatment of ARDS
Hurford et al. INHALED NO-HYPOTHESES
Lorenzoni et al. Inhaling one hundred percent oxygen eliminates the systemic arterial hypoxemic response of broilers to intravenous microparticle injections

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued